Cargando…
Rituximab therapy after pediatric hematopoietic stem cell transplantation can cause prolonged B-cell impairment and increases the risk for infections - a retrospective matched cohort study
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827155/ https://www.ncbi.nlm.nih.gov/pubmed/36134454 http://dx.doi.org/10.3324/haematol.2022.281134 |
| _version_ | 1784867013113413632 |
|---|---|
| author | Launspach, Michael Temel, Dennis Ohlendorf, Emily Zirngibl, Felix Materne, Bianca Oevermann, Lena Deubzer, Hedwig E. Henssen, Anton G. Künkele, Annette Hundsdörfer, Patrick von Bernuth, Horst Pruß, Axel Eggert, Angelika von Stackelberg, Arend Lang, Peter Schulte, Johannes H. |
| author_facet | Launspach, Michael Temel, Dennis Ohlendorf, Emily Zirngibl, Felix Materne, Bianca Oevermann, Lena Deubzer, Hedwig E. Henssen, Anton G. Künkele, Annette Hundsdörfer, Patrick von Bernuth, Horst Pruß, Axel Eggert, Angelika von Stackelberg, Arend Lang, Peter Schulte, Johannes H. |
| author_sort | Launspach, Michael |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9827155 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98271552023-01-20 Rituximab therapy after pediatric hematopoietic stem cell transplantation can cause prolonged B-cell impairment and increases the risk for infections - a retrospective matched cohort study Launspach, Michael Temel, Dennis Ohlendorf, Emily Zirngibl, Felix Materne, Bianca Oevermann, Lena Deubzer, Hedwig E. Henssen, Anton G. Künkele, Annette Hundsdörfer, Patrick von Bernuth, Horst Pruß, Axel Eggert, Angelika von Stackelberg, Arend Lang, Peter Schulte, Johannes H. Haematologica Letter to the Editor Fondazione Ferrata Storti 2022-09-22 /pmc/articles/PMC9827155/ /pubmed/36134454 http://dx.doi.org/10.3324/haematol.2022.281134 Text en Copyright© 2023 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letter to the Editor Launspach, Michael Temel, Dennis Ohlendorf, Emily Zirngibl, Felix Materne, Bianca Oevermann, Lena Deubzer, Hedwig E. Henssen, Anton G. Künkele, Annette Hundsdörfer, Patrick von Bernuth, Horst Pruß, Axel Eggert, Angelika von Stackelberg, Arend Lang, Peter Schulte, Johannes H. Rituximab therapy after pediatric hematopoietic stem cell transplantation can cause prolonged B-cell impairment and increases the risk for infections - a retrospective matched cohort study |
| title | Rituximab therapy after pediatric hematopoietic stem cell transplantation can cause prolonged B-cell impairment and increases the risk for infections - a retrospective matched cohort study |
| title_full | Rituximab therapy after pediatric hematopoietic stem cell transplantation can cause prolonged B-cell impairment and increases the risk for infections - a retrospective matched cohort study |
| title_fullStr | Rituximab therapy after pediatric hematopoietic stem cell transplantation can cause prolonged B-cell impairment and increases the risk for infections - a retrospective matched cohort study |
| title_full_unstemmed | Rituximab therapy after pediatric hematopoietic stem cell transplantation can cause prolonged B-cell impairment and increases the risk for infections - a retrospective matched cohort study |
| title_short | Rituximab therapy after pediatric hematopoietic stem cell transplantation can cause prolonged B-cell impairment and increases the risk for infections - a retrospective matched cohort study |
| title_sort | rituximab therapy after pediatric hematopoietic stem cell transplantation can cause prolonged b-cell impairment and increases the risk for infections - a retrospective matched cohort study |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827155/ https://www.ncbi.nlm.nih.gov/pubmed/36134454 http://dx.doi.org/10.3324/haematol.2022.281134 |
| work_keys_str_mv | AT launspachmichael rituximabtherapyafterpediatrichematopoieticstemcelltransplantationcancauseprolongedbcellimpairmentandincreasestheriskforinfectionsaretrospectivematchedcohortstudy AT temeldennis rituximabtherapyafterpediatrichematopoieticstemcelltransplantationcancauseprolongedbcellimpairmentandincreasestheriskforinfectionsaretrospectivematchedcohortstudy AT ohlendorfemily rituximabtherapyafterpediatrichematopoieticstemcelltransplantationcancauseprolongedbcellimpairmentandincreasestheriskforinfectionsaretrospectivematchedcohortstudy AT zirngiblfelix rituximabtherapyafterpediatrichematopoieticstemcelltransplantationcancauseprolongedbcellimpairmentandincreasestheriskforinfectionsaretrospectivematchedcohortstudy AT maternebianca rituximabtherapyafterpediatrichematopoieticstemcelltransplantationcancauseprolongedbcellimpairmentandincreasestheriskforinfectionsaretrospectivematchedcohortstudy AT oevermannlena rituximabtherapyafterpediatrichematopoieticstemcelltransplantationcancauseprolongedbcellimpairmentandincreasestheriskforinfectionsaretrospectivematchedcohortstudy AT deubzerhedwige rituximabtherapyafterpediatrichematopoieticstemcelltransplantationcancauseprolongedbcellimpairmentandincreasestheriskforinfectionsaretrospectivematchedcohortstudy AT henssenantong rituximabtherapyafterpediatrichematopoieticstemcelltransplantationcancauseprolongedbcellimpairmentandincreasestheriskforinfectionsaretrospectivematchedcohortstudy AT kunkeleannette rituximabtherapyafterpediatrichematopoieticstemcelltransplantationcancauseprolongedbcellimpairmentandincreasestheriskforinfectionsaretrospectivematchedcohortstudy AT hundsdorferpatrick rituximabtherapyafterpediatrichematopoieticstemcelltransplantationcancauseprolongedbcellimpairmentandincreasestheriskforinfectionsaretrospectivematchedcohortstudy AT vonbernuthhorst rituximabtherapyafterpediatrichematopoieticstemcelltransplantationcancauseprolongedbcellimpairmentandincreasestheriskforinfectionsaretrospectivematchedcohortstudy AT prußaxel rituximabtherapyafterpediatrichematopoieticstemcelltransplantationcancauseprolongedbcellimpairmentandincreasestheriskforinfectionsaretrospectivematchedcohortstudy AT eggertangelika rituximabtherapyafterpediatrichematopoieticstemcelltransplantationcancauseprolongedbcellimpairmentandincreasestheriskforinfectionsaretrospectivematchedcohortstudy AT vonstackelbergarend rituximabtherapyafterpediatrichematopoieticstemcelltransplantationcancauseprolongedbcellimpairmentandincreasestheriskforinfectionsaretrospectivematchedcohortstudy AT langpeter rituximabtherapyafterpediatrichematopoieticstemcelltransplantationcancauseprolongedbcellimpairmentandincreasestheriskforinfectionsaretrospectivematchedcohortstudy AT schultejohannesh rituximabtherapyafterpediatrichematopoieticstemcelltransplantationcancauseprolongedbcellimpairmentandincreasestheriskforinfectionsaretrospectivematchedcohortstudy |